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A non-recoverable hybridoma limits the production of monoclonal antibodies
against bovine trophoblast non-classical NC3*00101 protein
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The non-classical MHC class I (MHC-Ib) proteins are important modulators of immune system during pregnancy
favoring survival of the fetus. Contrary to ubiquitously expressed classical MHC-I proteins, MHC-Ib proteins are
oligomorphic, and expressed in specific cell/tissue types thus minimizing maternal immune-mediated rejection of fetalallograft and a successful pregnancy. A unique characteristic of MHC-Ib glycoproteins is expression of surface and soluble
isoforms due to alternative splicing phenomenon. Bovine fetal trophoblast cells, during the third trimester of pregnancy,
express non-classical bovine leukocyte antigen class Ib (BoLA-Ib) antigens. BoLA-NC3*00101, is a non-classical class I
allele from cattle AH11 haplotype and is expressed as cell surface isoform. However, lack of monoclonal antibody (mAb)
hinders the development of specific assay to detect the soluble/secreted BoLA-I antigens released by fetal trophoblast cells.
The objective of this study is to synthesize mAb specific to NC3*00101 molecule to develop an isotype-matched ELISA to
assess BoLA-I protein(s). We demonstrated that majority of NC3*00101 hybridoma-supernatants were low-titer and showed
inappreciable reactivity in ELISA and flow cytometry assays. We identified a clone of hybridoma (NC3-3*2) that secreted
mAb specific to BoLA-NC3*00101 as demonstrated with flow cytometry. NC3-3*2 clone secreted supernatant that captured
BoLA-NC3*00101 protein in ELISA. Unfortunately, despite several efforts we could not recover the cryopreserved
hybridoma. Non-recoverability and instability, thus, limited production of NC3*00101-mAbs. This study provides the
evidence that mice immunized with bovine class Ib proteins elicit a specific immunogenic response and warrants future
studies into generation of stable hybridoma secreting antibodies against BoLA-Ib proteins using robust methods of fusion
and cryopreservation of hybridomas.
Keywords: Bovine leukocyte antigen (BoLA), Non-classical NC3*00101 protein, Monoclonal antibodies, Hybridoma,
Trophoblast, P815 cell line

The major histocompatibility complex (MHC)
genetic region encodes the MHC-I and -II
transplantation antigens1. Classical MHC-I (MHC-Ia)
molecules are extremely polymorphic and
ubiquitously expressed and present intracellular
foreign or non–self-pathogen-derived peptides to
CD8+ T lymphocytes. Consequently, they are
involved in the acceptance or rejection of tissue grafts
based on the degree of similarity of these proteins
among the donor and recipient cells. An allogeneic
fetus must remain unharmed by the mother’s
potentially hostile immune system throughout the
—————
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term for a successful pregnancy. Discovery of nonclassical MHC-I proteins (MHC-Ib/class Ib), such as
human leukocyte antigen (HLA)-E, -F, and -G2 in
humans and Qa-2 in mice3,4, led to a new paradigm of
fetal immune tolerance. They play an immunemodulatory role and possess the following major
characteristics, which make them uniquely different
from MHC-Ia proteins5: (a) MHC-Ib proteins are
oligomorphic or monomorphic; (b) Their expression
is conditional and/or tissue specific; and (c) They are
produced as surface and/or soluble isoforms as a
result of alternative or differential splicing.
One major function of class Ib proteins is that they
mediate inhibitory and activating stimuli and inhibit
the lytic properties of uterine natural killer cells
contributing to fetomaternal tolerance6. Notably,
HLA-G is a potent immunomodulatory antigen
expressed by invasive cytotrophoblast cells and is
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encoded as surface and soluble isoforms. Soluble
HLA-G is present in maternal blood during
pregnancy, and a low concentration of it has been
found to be associated with pregnancy failure7.
Moreover, soluble HLA-G is secreted by human
embryos before implantation and is associated with a
higher implantation rate, uninterrupted gestation, and
more live births resulting from in vitro fertilization8.
Expression of HLA-G increases the cleavage rate of
human embryos and plays an important role in
embryonic development9.
The bovine MHC region (bovine leukocyte antigen
[BoLA]) is divided into three regions—I, II, and III—
each of which encodes proteins with different
functions10. The BoLA-Ia locus encodes at least six
classical class I genes, which are expressed in a
number of different combinations11. Transcripts
from BoLA-Ib loci have been attributed to the
BoLA-NC1, BoLA-NC2, BoLA-NC3, and BoLA-NC4
glycoproteins. Analogous to other class Ib proteins,
BoLA-Ib proteins have putative amino acid motifs in
their exons and are expressed specifically in
trophoblast cells. BoLA-NC1 also is expressed as a
surface isoform (NC1*00501) and a soluble/secreted
isoform (NC1*00101)12.
Evaluation of soluble and/or secreted BoLA-Ib
proteins released by embryos and trophoblast culture
supernatant is vital to understanding the role of class
Ib proteins in bovine embryonic development and the
establishment of pregnancy. However, unavailability
of a monoclonal antibody to BoLA-Ib proteins is a
caveat to developing a quantitative enzyme-linked
immunosorbent assay (ELISA). Monoclonal antibody
production technology discovered by Kohler and
Milstein13 not only enables researchers to isolate a
specific antibody from a complex mixture of
polyclonal antibodies present in the in vivo
immunization response; it also allows scientists to
culture hybridomas and produce antibodies in large
quantities in vitro when required. By virtue of their
specificity to a single epitope, monoclonal antibodies
decrease background noise and cross-reactivity with
nonspecific antigens. Monoclonal antibodies have
been used in various diagnostic tests to detect minute
quantities of antigens such as hormones, enzymes,
drugs, and toxins. For instance, human chorionic
gonadotropin is detected in urine or serum to diagnose
pregnancy in humans; acquired immune deficiency
syndrome is diagnosed using the ELISA test14-16.
In this study, we used the BoLA-NC3*00101
protein to immunize mice to generate monoclonal

antibodies and thus to develop an ELISA that can be
used to detect secreted or soluble BoLA-NC3*00101
and possibly other secreted or soluble bovine MHC-Ib
proteins produced from trophoblast cells and
embryos. Detection of the BoLA-NC3*00101 protein
in serum/trophoblast supernatant is instrumental to
understand the association between pregnancy success
rate and the expression level of this protein.
Materials and Methods
Cell line and transfection with bovine NC3*00101 cDNA

Murine mastocytoma P815 cells were used to
express NC3*00101 protein. Cells were cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM) with
10% bovine calf serum at 37C and 5% CO2. The cell
line was obtained from American Type Culture
Collection (ATCC, USA). Coding sequence for BoLANC3*00101 was amplified from complementary
deoxyribonucleic acid (cDNA) using specific primers
as below:
Forward primer (BoC1FP-E1B)
ACCATGGGGCCGCGAACCCTC
Reverse primer (BoC1RP-E7A)
TTTAGGAACCGTGAGAGACACATC
The reverse primer was designed to produce clones
expressing a 3’ 6x histidine tag and V5 epitope. The
pcDNA3.1™D/V5-His-TOPO® directional mammalian
expression vector (Invitrogen) was used for cloning
the cDNA and expressing the protein in mammalian
P815 cells. Positive clones were sequenced and a
perfect NC3*00101 clone was selected for
transfection. Cells were transfected as per the method
described earlier17. The transfected cells were
analyzed with flow cytometer to check initial
expression. Transfectants were selected with
Geneticin (G418) antibiotic and stably transfected
cells were sorted using fluorescence activated cell
sorter (FACS). The sorted high-expressing cells were
grown in T75 tissue culture flasks until they reached a
sufficient number to seed the pitched-blade
bioreactor17.
Flow cytometry and isolation of protein

The NC3*00101-trasnefected P815 cells were
stained for flow cytometry using the protocol
described earlier17. Briefly, cells were resuspended in
fluorescence buffer (FB) (PBS with 0.1% sodium
azide, 1% bovine serum albumin) and incubated with
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H1A antibody (15 µg/mL) for 15 min. Cells were
washed twice with FB and then incubated with
secondary antibody for 15 min. All incubations were
performed at 4C. Cells were washed twice and fixed
in PBS with 1% of 37% formaldehyde or
paraformaldehyde. One million cells were stained for
each sample. An irrelevant antibody ColiS169A was
used as a negative control. Cells were analyzed using
a Becton-Dickinson FACS (Fluorescence Activated
Cell Sorter) Aria II flow cytometer equipped with
FACS Diva software. The FACS-sorter was used to
sort and enrich the high expressing cells using
fluorescence buffer without sodium azide in it. For
hybridoma testing, we used supernatants as the
primary antibodies. NC3*00101-transfected cells
were stained with serum on flow cytometer.
Untransfected P815 cells were used as negative
control. Sorted cells were grown in large scale using a
pitched-blade bioreactor and protein was isolated
using affinity-column chromatography as explained
earlier. Specific NC3*00101 protein band was
identified with anti-V5 antibody on Western blot and
purified with affinity column chromatography as
explained earlier17.
ELISA screening of hybridoma supernatant

ELISA plates (CoStar Inc.) were coated with 16 µg/mL
of NC3*00101 antigen diluted in ELISA-AP binding
buffer (0.05M Tris, pH 9.5). The plate was incubated
overnight at 4°C. Plate was washed 4X with the
ELISA wash buffer (phosphate buffered saline, 0.1%
sodium azide, 0.05% Tween-20) and blocked for 2 h
at 37°C with blocking buffer (0.05M Tris, 0.3% BSA)
to block the non-specific protein binding sites. After
4X washes, antibodies H1A, W6/32, H6A, H11A and
hybridoma supernatants were added to the wells. The
antibody used per well was 1 µg. Antibodies were
diluted in dilution buffer-I. Plates were incubated at
37°C for 1 h and washed 4x. The secondary antibody
W6/32-biotin (Novus Biologicals) diluted in dilution
buffer-II was added and incubated for 1 h at 37°C.
After washing the plate four times, substrate buffer
(50 mM K2CO3, 1 µM MgCl2.6H2O) was added and
incubated for 1 h at 37°C. Finally, para-nitro
phenylphosphate (pNPP) solution (1 tablet of Sigma
104 phosphatase substrate in 5 mL of substrate buffer)
was added to the wells and incubated at 37°C. End
point reading was measured at OD 405 nm at every
15 min interval up to an hour. Data were analyzed
by plotting line graphs taking time on X axis and
OD on Y axis. We used diluted (1:100) and neat (1:1)
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NC3*00101-hybridoma culture supernatants in
ELISA.
For Sandwich ELISA the procedure was same as
mentioned above except that the plate was coated
with antibody or supernatant overnight at 4°C and
after blocking the plate, antigen was added. Sandwich
ELISA was intended to detect soluble bovine MHC-Ib
proteins. In other studies, a capture (sandwich) ELISA
procedure had been used to detect the soluble class-I
proteins7,8,18-20.
Purification of NC3*00101 protein

The method is detailed previously17. Briefly, cells
were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4;
150 mM NaCl with 1 mM mammalian protease
inhibitor Cocktail (Sigma), 1 mM PMSF) per 1 × 107
cells/mL of lysis buffer. After an hour of incubation at
4°C, the supernatant (lysate) was collected by
centrifugation at 10000 g for 15 min at 4°C.
Specific histidine-tagged protein was purified using
His-GraviTrap Columns (GE Healthcare). Eluates
which showed clear and high-intensity bands on
Western blots were pooled and resultant purified
protein solution was dialyzed against phosphate buffer
solution (20 mM sodium phosphate, 500 mM NaCl, pH
7.4) using 20 KDa MWCO Slide-A-Dialysis cassettes
(Pierce). Dialysates were centrifuged at maximum
speed for 10 min at 4C and the supernatant was
recovered in a fresh tube. The dialysates were
concentrated using Vivaspin-20 concentrators with
30 KD MWCO membranes (Vivaproducts Inc., USA).
The concentration of purified protein was measured
using a BCA protein assay kit (Thermo Scientific).
Monoclonal antibody production
Immunization

Antibodies to NC3*00101 protein were produced at
Washington State University (WSU) Monoclonal
Antibody Center following the protocol described by
Hamilton and Davis21. A total of three batches of
immunizations were conducted for the NC3*00101.
Each batch, four mice were hyperimmunized with
purified antigen in Ribi’s Adjuvant (Sigma-Aldrich).
Each mouse was given three immunizations (d0, d14,
and d21) each with 50 µg antigen. Mice were bled
before each immunization and serum was collected.
Mouse serum ELISA was performed after d21 to
determine titer and a final booster dose of the
antigen without adjuvant was administered to mice
intravenously through the tail three days prior to
fusion of spleen cells and myeloma.
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Fusion

For each fusion, mice were euthanized and
spleen cells (plasma cells or B-lymphocytes) were
collected aseptically and pooled from four mice.
Approximately, 1 × 108 spleen cells were fused with
4 × 107 X63 Ag8.653 myeloma cells (Kearney et al.22)
following the protocol described earlier21. Fused cells
were resuspended in growth medium containing
hypoxanthine aminopterin and thymidine (HAT
medium) and cultured in ten 96-well culture plates.
Initial screening of Hybridoma

With the help of indirect ELISA and flow
cytometry, hybridoma supernatants were tested for
immunoglobulin of interest23. Positive hybridomas
were cloned or expanded in 12-well culture plates.
Two ampoules of hybridomas per culture were
collected and cryopreserved following expansion.
Additional supernatants were collected and
characterized with ELISA, flow cytometry and
Western Blotting.
Culture of hybridoma

We obtained live cultures of NC3*00101hybridoma (WSU, Antibody Center, Pullman) and
IL-A88 and IL-A19 hybridomas (Sigma-Aldrich).
They were cultured in RPMI with 1% Zap Hybridoma
(InVitria Inc., USA). Cells were enumerated and
cultured in a 6-well plate at the seeding concentration
1 × 106 cells/ mL of medium. After 1 week of culture,
cells were transferred to T25 flask. When cells were
~90% confluent, they were moved to T75 flasks.
Multiple T75 flasks were grown @ 5 million cells/50 mL
and grown for a week until cells died. The exhausted
supernatant containing antibodies was collected by
centrifugation at 1500 RPM for 10 min22.
Antibody isotyping of supernatants

All NC3*00101 supernatants were characterized
for their isotypes using a radio immune assay (RIA)
antibody isotyping kit (Pierce). H1A, W6/32 and
IL-A88 were used as positive controls.
Results
Flow cytometric analysis and Isolation of NC3*00101 protein
from FACS-sorted cells

Flow cytometric analysis of newly transfected
NC3*00101-P815 cells revealed <20% expression of
the protein, which increased to ~50% following
2 weeks of G418 selection. Following fluorescenceactivated cell sorting (FACS)-sorting of transfected
cell line with a pan-bovine MHC class I monoclonal

antibody (H1A), a high level of stable transgene
expression, usually >90% positive cells, was achieved.
An appreciable protein concentration (1.9 mg/mL)
was achieved following purification, yielding a
sufficient amount of protein for immunization of mice
(~600 µg for the immunization of three mice) and for
screening of initial sera, supernatants, and hybridomas.
The purified NC3*00101 protein (~minimum of
600 µg for immunization of three mice) was used for
immunization of mice and initial screening of the
hybridoma.
Screening of hybridoma supernatants

We screened the initial hybridomas using ELISA
and flow cytometry from three fusions performed at
WSU (Pullman, WA).
ELISA screening
First fusion

The NC3*00101 hybridomas were initially
screened with ELISA at the WSU Antibody
Development Center. Twelve positive NC3
hybridoma colonies were created from the first fusion.
NC3-1*4 and NC3-1*9 appeared to have a slightly
positive reaction in ELISA using 8 µg/mL of antigen
to coat the ELISA plate. The hybridomas NC3-1*4
and NC3-1*9 were slightly positive in ELISA. None
of the 12 sera was positive from the first fusion.
Second fusion

From the second fusion of spleen cells with
myeloma cells, one positive hybridoma (NC3-2*2)
was selected and sent to our laboratory for further
expansion and screening. However, we could not
identify positive reactivity of the NC3-2*2
supernatant in ELISA. By the time of the second
fusion, 12 clones derived from the first fusion were
identified as negative.
Third fusion

The NC3-3*7A and NC3-3*7B supernatants were
not positive when tested on ELISA. The reactivity
pattern of the NC3*00101 supernatants are summarized
in Table 1. Because the antibody titer was low in
all NC3-supernatants, we used neat supernatants. The
NC3-3*2 hybridoma supernatant showed a strong
reactivity, which was more obvious in ELISA
performed with neat supernatants than those with
1:100 dilution (Figs. 1 and 2). We endeavored to
clone the cryopreserved NC3-3*2 hybridoma, but
we failed to recuperate it. Consequently, we lost
our indefinite source of NC3*00101 monoclonal
antibodies. We also tested the NC3 hybridoma
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Table 1 — The summary of ELISA results of NC3 supernatants
mAb
H1A
W6/32
IL-A88 (1:1)
IL-A88 1:10
NC3-1*1
NC3-1*2
NC3-1*3
NC3-1*4
NC3-1*5
NC3-1*6
NC3-1*7
NC3-1*8
NC3-1*9
NC3-1*10
NC3-1*11
NC3-1*12
NC3-2*1
NC3-2*9
NC3-3*1
NC3-3*2
NC3-3*3

N*01701
++++
++++
+
++++
+
+
-

N*01802
++++
+++
++++
++++
+
++
+
+
-

NC3*00101
+++
++++
++++
+
++++
+
+
++++
-

Fig. 2 — ELISA screening of NC3*00101 supernatants when used
neat (1:1). [End points (Optical Density) were measured at four
time intervals of 15, 30, 45 and 60 min. Bovine classical class I
N*01701 and N*01802 and non-classical NC1*00501 antigens
were used as a control for H1A and IL-A88 antibodies. At 1:1
dilution NC3-3*2 hybridoma supernatant had positive reactivity
with NC3-00101 antigen. X-axis: Time points (15, 30, 45 and
60 min). Y-axis: Optical Density measured at time points]

supernatants to capture antigens in sandwich ELISA,
which did not yield promising results. We plan to
perform more fusions in the future using modified
protocols for immunization and cloning of hybridomas.
Flow cytometry screening
First fusion

None of the twelve sera was positive from the first
fusion.
Second fusion

Fig. 1 — ELISA screening of NC3*00101 supernatants (1:100
dilution). [NC3-hybridoma culture supernatants were tested with
ELISA and ODs were recorded at four time intervals of 15, 30, 45
and 60 min. Two bovine classical N*01701 and N*01802 and
another non-classical NC1*00501 protein to test specificity of
NC3*00101 supernatants. H1A and IL-A88 are bovine MHCspecific antibodies (broad). ColiS205D1 was used as a negative
control. All NC3*00101-supernatants were negative or not above
background except the NC3-3*2 hybridoma supernatant that had
positive reactivity with NC3-00101 antigen. X-axis: Time points
(15, 30, 45 and 60 min). Y-axis: Optical Density measured at
time points]

In flow cytometry screening of the hybridomas
NC3-2*1 and NC-2*9, supernatants reacted with all
the bovine MHC-I proteins, showing weaker
reactivity to untransfected P815 cells, which suggests
that these supernatants reacted with nonspecific cell
cycle antigen on mouse P815 cells. However, NC32*1 stained more strongly with the NC3*00101
protein than the other proteins. We did not detect any
specific reactivity in the NC3-2*9 supernatant.
Consequently, we decided not to clone NC3-2*1 and
NC3-2*9 hybridomas further, and the third fusion was
performed using the frozen splenocytes.
Third fusion

Initial flow cytometric screening from the third
fusion produced 10 NC3-positive clones, but 2 of them
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were expanded and cryopreserved. We received the
supernatants NC3-3*1, NC3-3*2, and NC3-3*3, which
were tested in flow c ytometry using 1:1 (neat) and
1:100 dilutions. The NC3-3*2 supernatant showed
specific reactivity with NC3*00101 transfectants
(Fig. 3) and thus was cloned. At WSU we attempted
twice to recuperate the NC3-3*2 hybridoma cell line,
but we failed to clone and rescue it. The third fusion
was done, but all the clones had nonspecific reactivity.
Additional supernatants (NC3-3*4, NC3-3*5, NC33*8, NC3-3*9, NC3-3*10, and NC3-3*11) were tested,
but none of them were positive on transfected cells
(Fig. 4). From the third fusion we cultured four cell

lines and tested them on flow cytometry: NC3-3*2,
NC3-3*4, NC3-3*7, and NC3-3*8. The NC3-3*7A
and 7B supernatants reacted strongly with the NC3
protein, but they also showed a nonspecific reaction
with untransfected P815 cells with the same intensity.
Antibody isotyping of supernatants

We characterized the classes and subclasses of
immunoglobulins secreted by NC3*00101 hybridomas.
Positive controls H1A, W6/32 and IL-A88 were of
IgG2a isotypes and possessed a kappa (κ) light chain.
All tested NC3*00101 hybridomas secreted antibodies
of IgG1 isotypes with Kappa (κ) light chain (Table 2).

Fig. 3 — Flow cytometry staining of NC3*00101 hybridoma supernatants from the third fusion. [BoLA-NC3*00101-transfected P815
cells were stained for flow cytometry and incubated with NC3-3*1, NC3-3*2 and NC3-3*3 supernatants. BoLA-NC3*00101-NC3Supernatant 2 neat had specific positive response without reacting with the classical N*01701- and non-classical NC1*00501–transfected
P815 cells. Untransfected P815 cells were used as negative control in the experiment. H1A is a positive control antibody which stains the
surface-expressed BoLA-I proteins. An irrelevant isotype-matched ColiS205D1 antibody served as negative control]
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Fig. 4 — Flow cytometry staining of NC3*00101 hybridoma supernatants (NC3-3*4, NC3-3*5, NC3-3*8, NC3-3*9, NC3-3*10, and
NC3-3*11) from the third fusion. [Untransfected (negative control) P815 (top two panels) and NC3*00101-transfected P815 cells (bottom
two panels) were stained with the hybridoma culture supernatants 4, 5, 8, 9, 10, and 11 from the third fusion. As shown, none of the
NC3* hybridoma culture supernatants was positive and none reacted specifically with the NC3*00101 protein. ColiS205D1 antibody was
used as a negative control. Anti-MHC class I antibody W6/32, H1A, and IL-A88 were used as positive control antibodies]
Table 2 — Summary of isotyping of representative
NC3*00101 supernatants
mAb
H1A
IL-A88
W6/32
NC3-3*2
NC3-1*5
NC3-1*6
NC3-1*9
NC3-1*10
NC3-1*11

Isotype
IgG2a
IgG2a
IgG2a
IgG1
IgG1
IgG1
IgG1
IgG1
IgG1

Light Chain
Kappa
Kappa
Kappa
Kappa
Kappa
Kappa
Kappa
Kappa
Kappa

Discussion
There is no specific monoclonal antibody to bovine
non-classical MHC-I proteins. The first report of
bovine monoclonal antibody to red blood cell
antigen24. Bovine MHC-I specific monoclonal
antibodies IL-A88 and IL-A19 were produced at
International Laboratory for Research on Animal
Diseases (ILRAD), Kenya. To develop ELISA to
detect secreted and/or soluble BoLA-Ib proteins from
the trophoblast cell culture supernatant, we used a
purified BoLA-NC3*00101 protein to immunize mice
with non-classical BoLA-NC3*00101 protein to
synthesize monoclonal antibodies. Almost none of the
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hybridoma supernatants tested on ELISA and flow
cytometry were positive. Nonetheless, we identified a
hybridoma cell line (NC3-3*2) which secreted
NC3*00101-specific antibodies which not only was
specific to NC3*00101-transfected cells on flow
cytometry but also captured purified NC3*00101
protein in ELISA when culture supernatant was used
as capture antibody. Unfortunately, despite several
efforts, we failed to recover the cryopreserved
positive NC3-3*2 hybridoma cell line.
A surface expressed MHC glycoprotein molecule
structurally possesses a heavy chain which is
covalently linked with β2-microglobulin or light chain
expressed endogenously. During culturing of mouse
cells transfected with bovine MHC-I heavy chain
cDNA bovine MHC-I protein is expressed combined
initially with the endogenously derived murine β2-M
that is swapped or exchanged with bovine β2-M from
bovine calf serum or fetal bovine serum used in the
culture media. Davies et al. 198725 in their study
identified that the MHC-I specific antibodies
recognized the heavy chain of MHC-I proteins and
not β2-M. They discovered that WSU-VMRD mAbs
(H1A, H6A, H11A, and PT-85A) did not work on
western blot, but in non-reducing conditions, they all
reacted with the light chain (β2-M) as reported by Li
et al.26. It is possible that these antibodies only
recognized the cattle MHC-I proteins in which the
murine β2-M is replaced by bovine β2-M from the
serum used. These antibodies, could not be used to
specifically detect bovine MHC-Ia and –Ib proteins in
culture supernatant. We require an antibody which
can detect a single epitope conserved in secreted
classical and non-classical bovine MHC-I proteins
and provide a way to quantitate these proteins
released from cells and tissues during pregnancy.
Despite the non-recoverability of the only positive
hybridoma in the present study, we have observed
some interesting findings in this study project.
Importantly, mice immunized with bovine nonclassical class I protein NC3*00101 elicits an
immunogenic response. A research group used
transfected cells to immunize host to achieve the
production of immunoglobulins27. We also observed
that except the NC3-3*2 hybridoma, all hybridomas
showed positive staining with untransfected cells
which raises questions about the use of appropriate
host and/or purified protein derivative to immunize
mice. Non-positive hybridomas and lack of ability to
recover cryopreserved clonal cells beg us to rethink
on choosing a more suitable form of immunogen for

the host. Transfected cells can be better immunogens
than protein to avoid background and non-specificity.
Murine P815 cells are broad host cell line for
transfection studies used by various research groups.
These cells express endogenous murine MHC-I which
may interfere with binding of bovine MHC-I protein
expression. An MHC-I null cell line such as human
K562 can also be used for expressing bovine class I
transgenes. It may also be worth choosing an
alternative host animal for immunization.
Hybridoma stability is affected by various factors
such as mutations, chromosome losses and the
monoclonal antibody process variables28. Moreover,
selection of adjuvants, cryopreservation of polyclonal
and monoclonal hybridomas and their limiting
dilution are the parameters of consideration for
generation of antibodies29,30. In future, we intend to
perform repeated cloning and fusions or a
combination of thereof. In flow cytometric and
ELISA screens performed on hybridomas and culture
supernatant respectively, a typical non-specific
reactivity was observed except one specific NC3-3*2
hybridoma clone that was non-recoverable. Thus, data
indicate that we had very low-titer/non-specific
antibodies in supernatants and a rigorous cloning of
cryopreserved hybridomas is required to produce a
stable clone of hybridoma cell line.
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